25 related articles for article (PubMed ID: 7921026)
1. Mechanistic interpretation of promoter-proximal peaks and RNAPII density maps.
Ehrensberger AH; Kelly GP; Svejstrup JQ
Cell; 2013 Aug; 154(4):713-5. PubMed ID: 23953103
[No Abstract] [Full Text] [Related]
2. Functional characterization of the principal sigma factor RpoD of phytoplasmas via an in vitro transcription assay.
Miura C; Komatsu K; Maejima K; Nijo T; Kitazawa Y; Tomomitsu T; Yusa A; Himeno M; Oshima K; Namba S
Sci Rep; 2015 Jul; 5():11893. PubMed ID: 26150080
[TBL] [Abstract][Full Text] [Related]
3. A novel, non-radioactive eukaryotic in vitro transcription assay for sensitive quantification of RNA polymerase II activity.
Voss C; Schmitt B; Werner-Simon S; Lutz C; Simon W; Anderl J
BMC Mol Biol; 2014 Apr; 15():7. PubMed ID: 24694320
[TBL] [Abstract][Full Text] [Related]
4. Developmental specificity of recruitment of TBP to the TATA box of the human gamma-globin gene.
Duan ZJ; Fang X; Rohde A; Han H; Stamatoyannopoulos G; Li Q
Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5509-14. PubMed ID: 11960008
[TBL] [Abstract][Full Text] [Related]
5. Distamycin A and tallimustine inhibit TBP binding and basal in vitro transcription.
Bellorini M; Moncollin V; D'Incalci M; Mongelli N; Mantovani R
Nucleic Acids Res; 1995 May; 23(10):1657-63. PubMed ID: 7784168
[TBL] [Abstract][Full Text] [Related]
6. Rigorous and quantitative assay of transcription in vitro.
Zhang H; Iler N; Abate-Shen C
Methods Enzymol; 1996; 273():86-99. PubMed ID: 8791601
[No Abstract] [Full Text] [Related]
7. [Template-bound RNA polymerase II is concentrated in the nuclear skeleton-contiguous DNA fraction and preserves the capability of elongating the RNA chains in nuclear matrix preparations].
Razin SV; Iarovaia OV; Georgiev GP
Dokl Akad Nauk SSSR; 1985; 281(1):220-3. PubMed ID: 3996203
[No Abstract] [Full Text] [Related]
8. Kinetic and mechanistic analysis of the RNA polymerase II transcrption reaction at the human interleukin-2 promoter.
Ferguson HA; Kugel JF; Goodrich JA
J Mol Biol; 2001 Dec; 314(5):993-1006. PubMed ID: 11743717
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of RNA polymerase II transcription in human cell extracts by cisplatin DNA damage.
Cullinane C; Mazur SJ; Essigmann JM; Phillips DR; Bohr VA
Biochemistry; 1999 May; 38(19):6204-12. PubMed ID: 10320349
[TBL] [Abstract][Full Text] [Related]
10. Three transitions in the RNA polymerase II transcription complex during initiation.
Holstege FC; Fiedler U; Timmers HT
EMBO J; 1997 Dec; 16(24):7468-80. PubMed ID: 9405375
[TBL] [Abstract][Full Text] [Related]
11. Nuclear myosin I is necessary for the formation of the first phosphodiester bond during transcription initiation by RNA polymerase II.
Hofmann WA; Vargas GM; Ramchandran R; Stojiljkovic L; Goodrich JA; de Lanerolle P
J Cell Biochem; 2006 Nov; 99(4):1001-9. PubMed ID: 16960872
[TBL] [Abstract][Full Text] [Related]
12. An RNA polymerase II in vitro transcription system.
Mantovani R
Methods Mol Biol; 1994; 31():289-98. PubMed ID: 7921026
[No Abstract] [Full Text] [Related]
13. The cell cycle.
Baserga R
N Engl J Med; 1981 Feb; 304(8):453-9. PubMed ID: 6161307
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]